IPOs
-
IPO-Bound Anthropic Is Reportedly Teaming Up With Blackstone, Goldman Sachs In $1.5B Joint Venture To Sell AI
The JV aims to push Anthropic services to private-equity backed companies, The Wall Street Journal reported, adding that the deal…
Read More » -
The SpaceX IPO Will Create a $75 Billion Spending Spree — These 2 AI Stocks Will Win
The upcoming SpaceX IPO should make history. There are already ways to invest in SpaceX today. But these methods are…
Read More » -
Billionaire Bill Ackman’s new IPO lands with a thud
Billionaire investor Bill Ackman’s newly launched U.S.-listed investment vehicle stumbled on its market debut. On April 29, its first day…
Read More » -
Hemab Therapeutics IPO Debut Puts COAG And Pipeline Risks In Focus
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors…
Read More » -
SpaceX IPO: Is This the 10X Stock You’ve Been Waiting For?
Key Points SpaceX may be targeting a $2 trillion valuation. Analysts are split on whether a $2 trillion valuation is…
Read More » -
Elon Musk’s SpaceX Could Be Fast-Tracked Into S&P 500 After IPO Under Proposed Rule Changes
The S&P 500, managed by S&P Global Dow Jones Indices, on Thursday, announced it was beginning consultation on rule changes…
Read More » -
IPO News – US IPO Weekly Winners & Losers
Biotech IPOs just capped off their biggest month in 5+ years. Four drug developers raised a combined $1.5 billion in…
Read More » -
Kailera Therapeutics IPO And Governance Shift Draw Investor Attention
Kailera Therapeutics, NasdaqGS:KLRA, completed its initial public offering and began trading as a public company. The company implemented a restated…
Read More » -
IPO News – US IPO Week Ahead: May IPO market kicks off with defense tech and soft drinks
Two IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late.…
Read More » -
Fannie Mae Downgraded by Wedbush After Q1; Ackman and Investors Stay Focused on Long-Term IPO Potential
Fannie Mae (OTC: FNMA) was downgraded to Neutral from Outperform by Wedbush following its first-quarter earnings report, as valuation concerns…
Read More »